394 related articles for article (PubMed ID: 21757572)
1. Sex differences in the diagnosis, treatment, and outcome of patients with pulmonary arterial hypertension enrolled in the registry to evaluate early and long-term pulmonary arterial hypertension disease management.
Shapiro S; Traiger GL; Turner M; McGoon MD; Wason P; Barst RJ
Chest; 2012 Feb; 141(2):363-373. PubMed ID: 21757572
[TBL] [Abstract][Full Text] [Related]
2. Survival in childhood pulmonary arterial hypertension: insights from the registry to evaluate early and long-term pulmonary arterial hypertension disease management.
Barst RJ; McGoon MD; Elliott CG; Foreman AJ; Miller DP; Ivy DD
Circulation; 2012 Jan; 125(1):113-22. PubMed ID: 22086881
[TBL] [Abstract][Full Text] [Related]
3. Portopulmonary hypertension: a report from the US-based REVEAL Registry.
Krowka MJ; Miller DP; Barst RJ; Taichman D; Dweik RA; Badesch DB; McGoon MD
Chest; 2012 Apr; 141(4):906-915. PubMed ID: 21778257
[TBL] [Abstract][Full Text] [Related]
4. Functional class improvement and 3-year survival outcomes in patients with pulmonary arterial hypertension in the REVEAL Registry.
Barst RJ; Chung L; Zamanian RT; Turner M; McGoon MD
Chest; 2013 Jul; 144(1):160-168. PubMed ID: 23429998
[TBL] [Abstract][Full Text] [Related]
5. The changing picture of patients with pulmonary arterial hypertension in the United States: how REVEAL differs from historic and non-US Contemporary Registries.
Frost AE; Badesch DB; Barst RJ; Benza RL; Elliott CG; Farber HW; Krichman A; Liou TG; Raskob GE; Wason P; Feldkircher K; Turner M; McGoon MD
Chest; 2011 Jan; 139(1):128-37. PubMed ID: 20558556
[TBL] [Abstract][Full Text] [Related]
6. Five-Year outcomes of patients enrolled in the REVEAL Registry.
Farber HW; Miller DP; Poms AD; Badesch DB; Frost AE; Muros-Le Rouzic E; Romero AJ; Benton WW; Elliott CG; McGoon MD; Benza RL
Chest; 2015 Oct; 148(4):1043-54. PubMed ID: 26066077
[TBL] [Abstract][Full Text] [Related]
7. Effect of Warfarin Treatment on Survival of Patients With Pulmonary Arterial Hypertension (PAH) in the Registry to Evaluate Early and Long-Term PAH Disease Management (REVEAL).
Preston IR; Roberts KE; Miller DP; Sen GP; Selej M; Benton WW; Hill NS; Farber HW
Circulation; 2015 Dec; 132(25):2403-11. PubMed ID: 26510696
[TBL] [Abstract][Full Text] [Related]
8. Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL).
Benza RL; Miller DP; Gomberg-Maitland M; Frantz RP; Foreman AJ; Coffey CS; Frost A; Barst RJ; Badesch DB; Elliott CG; Liou TG; McGoon MD
Circulation; 2010 Jul; 122(2):164-72. PubMed ID: 20585012
[TBL] [Abstract][Full Text] [Related]
9. Demographics and outcomes of patients diagnosed with pulmonary hypertension with pulmonary capillary wedge pressures 16 to 18 mm Hg: insights from the REVEAL Registry.
Frost AE; Farber HW; Barst RJ; Miller DP; Elliott CG; McGoon MD
Chest; 2013 Jan; 143(1):185-195. PubMed ID: 22661451
[TBL] [Abstract][Full Text] [Related]
10. Comorbid conditions and outcomes in patients with pulmonary arterial hypertension: a REVEAL registry analysis.
Poms AD; Turner M; Farber HW; Meltzer LA; McGoon MD
Chest; 2013 Jul; 144(1):169-176. PubMed ID: 23348820
[TBL] [Abstract][Full Text] [Related]
11. An evaluation of long-term survival from time of diagnosis in pulmonary arterial hypertension from the REVEAL Registry.
Benza RL; Miller DP; Barst RJ; Badesch DB; Frost AE; McGoon MD
Chest; 2012 Aug; 142(2):448-456. PubMed ID: 22281797
[TBL] [Abstract][Full Text] [Related]
12. Four- and seven-year outcomes of patients with congenital heart disease-associated pulmonary arterial hypertension (from the REVEAL Registry).
Barst RJ; Ivy DD; Foreman AJ; McGoon MD; Rosenzweig EB
Am J Cardiol; 2014 Jan; 113(1):147-55. PubMed ID: 24176071
[TBL] [Abstract][Full Text] [Related]
13. Systemic BP and heart rate as prognostic indicators in pulmonary arterial hypertension.
Bersohn MM; Turner MP; Traiger GL; Frost AE; Shapiro S
Chest; 2013 Sep; 144(3):959-965. PubMed ID: 23598723
[TBL] [Abstract][Full Text] [Related]
14. Characterization of first-time hospitalizations in patients with newly diagnosed pulmonary arterial hypertension in the REVEAL registry.
Burger CD; Long PK; Shah MR; McGoon MD; Miller DP; Romero AJ; Benton WW; Safford RE
Chest; 2014 Nov; 146(5):1263-1273. PubMed ID: 24901386
[TBL] [Abstract][Full Text] [Related]
15. Unique predictors of mortality in patients with pulmonary arterial hypertension associated with systemic sclerosis in the REVEAL registry.
Chung L; Farber HW; Benza R; Miller DP; Parsons L; Hassoun PM; McGoon M; Nicolls MR; Zamanian RT
Chest; 2014 Dec; 146(6):1494-1504. PubMed ID: 24992469
[TBL] [Abstract][Full Text] [Related]
16. Characterization of connective tissue disease-associated pulmonary arterial hypertension from REVEAL: identifying systemic sclerosis as a unique phenotype.
Chung L; Liu J; Parsons L; Hassoun PM; McGoon M; Badesch DB; Miller DP; Nicolls MR; Zamanian RT
Chest; 2010 Dec; 138(6):1383-94. PubMed ID: 20507945
[TBL] [Abstract][Full Text] [Related]
17. Delay in recognition of pulmonary arterial hypertension: factors identified from the REVEAL Registry.
Brown LM; Chen H; Halpern S; Taichman D; McGoon MD; Farber HW; Frost AE; Liou TG; Turner M; Feldkircher K; Miller DP; Elliott CG
Chest; 2011 Jul; 140(1):19-26. PubMed ID: 21393391
[TBL] [Abstract][Full Text] [Related]
18. Prognostic implications of serial risk score assessments in patients with pulmonary arterial hypertension: a Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL) analysis.
Benza RL; Miller DP; Foreman AJ; Frost AE; Badesch DB; Benton WW; McGoon MD
J Heart Lung Transplant; 2015 Mar; 34(3):356-61. PubMed ID: 25447572
[TBL] [Abstract][Full Text] [Related]
19. Anticoagulation and survival in pulmonary arterial hypertension: results from the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA).
Olsson KM; Delcroix M; Ghofrani HA; Tiede H; Huscher D; Speich R; Grünig E; Staehler G; Rosenkranz S; Halank M; Held M; Lange TJ; Behr J; Klose H; Claussen M; Ewert R; Opitz CF; Vizza CD; Scelsi L; Vonk-Noordegraaf A; Kaemmerer H; Gibbs JS; Coghlan G; Pepke-Zaba J; Schulz U; Gorenflo M; Pittrow D; Hoeper MM
Circulation; 2014 Jan; 129(1):57-65. PubMed ID: 24081973
[TBL] [Abstract][Full Text] [Related]
20. Validation of the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL) pulmonary hypertension prediction model in a unique population and utility in the prediction of long-term survival.
Cogswell R; Kobashigawa E; McGlothlin D; Shaw R; De Marco T
J Heart Lung Transplant; 2012 Nov; 31(11):1165-70. PubMed ID: 23062726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
